tirzepatide news november 2025 Trump announces major deal to lower cost of weight loss medications Boston, USA. 16th Nov, 2025.

Summary: Findings revealed a profound therapeutic benefit: GLP-1 receptor agonists (such as semaglutide, tirzepatide, and liraglutide) do not merely drive physical weight reduction

In the meantime, the GLP-1 discontinuation wave from Semaglutide and Tirzepatide alone is already creating significant downstream demand, for metabolic support products, muscle preservation, and micronutrient replenishment

Compounded semaglutide is an alternative for people who need a custom dose or formulation that is not commercially available

This schedule may change once the FDA reviews the final data

I kept reacting to more and more things, so I would eliminate more things, until those two clients that got better with liver support inspired me to dig into toxins, and support my own liver as well